---
schema_version: research-idea-narrative-assessment.v1
assessment_id: narrative-assessment-I01-001-r126
review_id: narrative-review-I01-001-r126
reviewer_skill: idea-narrative-assessor
reviewer_instance_id: old-v055-blind-narrative-r126
workflow_id: RID-SEPSIS-CSM-20260717-001
round_id: r126
input_artifact_ids:
  - idea-dossier-I01-001-v055
input_versions:
  - v055
input_dossier:
  artifact_id: idea-dossier-I01-001-v055
  version: v055
  path: tests/idea-narrative-forward-0.9.0-preview.3/one-pass-current/direct-final-current-v21/idea-dossier-v055.md
reader_handoff:
  artifact_id: embedded-reader-handoff
  version: dossier-declared-audience-v055
  path: null
files_read:
  - tests/idea-narrative-forward-0.9.0-preview.3/one-pass-current/direct-final-current-v21/idea-dossier-v055.md
isolation_mode: fresh_subagent
prior_scores_visible: false
forbidden_project_artifacts_read: false
source_edits_performed: false
decision: major_narrative_revision
findings:
  - finding_id: NAR-001
    severity: major
    category: conditional-extension prominence and repetition
    dossier_locator:
      section_heading: Research design and methods
      subsection_heading: 试验观测映射和独立分析
      content_anchor: '**共享前提。** 启动任何新访视结局分析前'
    observed_evidence: >-
      The subsection appropriately contains the complete eligibility, mapping, alternative-endpoint,
      analysis, and stopping logic for the post-24-month trial extension, but substantial parts of
      that same logic are re-explained in the summary, abstract, objectives, work packages, resource
      status, evidence chain, required analyses, planned outputs, falsification criteria,
      interpretation matrix, contribution ladder, claim-support table, limitations, and risk table.
    current_reader_effect: >-
      A reader repeatedly leaves the declared 24-month stage I–II route to process a contingent
      downstream component, so the extension acquires narrative weight comparable to the main study
      despite repeated statements that it is subordinate.
    target_function: >-
      Keep one complete technical authority for the conditional trial extension and retain only the
      minimum role-specific statement needed in each other required section, so the stage I–II
      evidence route remains visibly primary.
  - finding_id: NAR-002
    severity: major
    category: caveat saturation and duplicated limitations
    dossier_locator:
      section_heading: Feasibility, resources, risks, alternatives, and stop conditions
      subsection_heading: Limitations and boundary conditions
      content_anchor: '1. **资源、访问与团队状态：**'
    observed_evidence: >-
      Section 14 provides a complete eleven-item limitations authority, while the same access,
      support, test-isolation, noncausal-interpretation, trial-semantics, and unverified-result
      boundaries recur across the opening, resource tables, methods, required analyses, outputs,
      contribution material, feasibility prose, and risk table even when no new local decision is
      introduced.
    current_reader_effect: >-
      Repeated qualifications fragment the positive argument and make it difficult to distinguish a
      scientific limitation from an operational status, an analysis eligibility rule, or a stopping
      consequence that performs a distinct local function.
    target_function: >-
      Preserve section 14 as the sole complete limitations authority; elsewhere retain only concise,
      self-contained boundaries that are necessary to understand the immediately adjacent design,
      status, evidence-chain, interpretation, or risk function.
  - finding_id: NAR-003
    severity: minor
    category: qualifier-stacked summary and first-use concept burden
    dossier_locator:
      section_heading: Title, summary, audience, and positioning
      subsection_heading: null
      content_anchor: '**One-sentence complete-Idea summary:** 本研究计划在 24 个月内'
    observed_evidence: >-
      The single sentence combines the 24-month scope, evidence sources, full disease continuum,
      knowledge constraints, uncertainty, simulation reconstruction, cross-database testing, the
      conditional trial extension, and the noncausal boundary before the cross-disciplinary reader
      has a plain account of what the candidate representation does.
    current_reader_effect: >-
      Critical-care, epidemiology, statistics, system-identification, artificial-intelligence, and
      translational readers must unpack several specialty-specific constructs and nested conditions
      before they can restate the positive study aim after one pass.
    target_function: >-
      Make the one-sentence summary lead with the study object, main question, and planned stage I–II
      contribution, while preserving only identity-defining boundaries and explaining necessary
      cross-disciplinary constructs at first use.
unresolved_issues: []
---

# Narrative assessment

## Overall judgment

The dossier requires major narrative revision. Its central reasoning chain is already complete and
coherent: the background establishes the time-dependent sepsis problem, the current-state section
identifies fragmented prior approaches, the gap asks whether one bounded representation can cover the
continuum, the significance explains the value of distinguishing task-specific success from broader
stability, and the rationale connects that gap to dual clocks, process separation, simulation recovery,
and frozen cross-database testing. The title, primary question, objectives, main work packages, evidence
chains, and contribution frame also identify the same stage I–II study.

The reader's route nevertheless becomes substantially diluted after that strong opening. Full operating
logic for the conditional trial extension is repeatedly revisited outside its methods authority, and
complete or near-complete cautions recur outside the designated limitations section. Correcting those
patterns requires coordinated consolidation across many required sections rather than a few isolated
sentence edits. The opening summary adds a smaller but real first-pass comprehension burden.

## Findings

### NAR-001 — Conditional extension prominence and repetition

The post-24-month trial work is explicitly subordinate, but the dossier repeatedly explains its
eligibility, mapping branch, independent SOFA alternative, stopping rules, and interpretation boundary.
Those details are necessary in the dedicated methods subsection; elsewhere, most required functions can
be satisfied by a much shorter statement of the extension's specific input, output, or evidentiary role.
The present distribution makes readers repeatedly interrupt the main 24-month route and reconstruct
which material is primary.

### NAR-002 — Caveat saturation and duplicated limitations

The limitations subsection is a clear candidate for the single complete authority, but many of its
boundaries are restated throughout the dossier. Some local constraints are indispensable—for example, a
method eligibility rule, a resource-status entry, a falsification consequence, or an interpretation
boundary. Other occurrences merely repeat the same warning. The repair must distinguish these functions
carefully: preserve necessary local rules in self-contained form, retain the complete limitations only
in section 14, and remove repetitions that add no new reader function.

### NAR-003 — Qualifier-stacked summary and first-use concept burden

The one-sentence summary preserves the study's identity but attempts to carry nearly every major scope
condition at once. Because the declared audience spans clinical and technical specialties, the summary
should expose the study object, question, and planned contribution before requiring readers to parse the
technical representation and its evidence qualifications. This is a localized repair and should not
change any scientific boundary.

## Preserved strengths

- Preserve all 15 required H2 sections and the five distinct H3 reasoning functions under
  `Background, current state, gap, significance, and rationale`.
- Preserve the explicit separation of clinical-event and information-availability clocks, physiological
  state, treatment action, and measurement process.
- Preserve the stage I–II minimum route, the conjunctive success definition, the simple-model fallback,
  and the distinction among simulation recovery, clinical tasks, and untouched cross-database testing.
- Preserve all five evidence chains and their separate Input, Method / analysis / processing, Output,
  and Supports functions.
- Preserve the conditional status of stage III, the separation of the two trials, and the noncausal
  interpretation boundary; reduce repetition without weakening any of them.
- Preserve section 14 as the full limitations and assumptions authority, together with locally necessary
  status, eligibility, falsification, interpretation, and stopping functions.

## Handoff

See the paired `narrative-repair-plan-r126.yaml` for executable actions.
